EMBR LABS SECURES $35 MILLION TO FUND MARKET EXPANSION
Embr Labs (S16), maker of the first wearable device to treat menopause symptoms, has raised $35 million in funding. This financial support will drive consumer growth through retail expansion and geographic reach, changing lives by relieving menopausal symptoms through temperature control at the touch of a button.